These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1015 related items for PubMed ID: 7699334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG.
    J Immunol; 1998 Dec 01; 161(11):6171-9. PubMed ID: 9834103
    [Abstract] [Full Text] [Related]

  • 3. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells.
    Probst P, Skeiky YA, Steeves M, Gervassi A, Grabstein KH, Reed SG.
    Eur J Immunol; 1997 Oct 01; 27(10):2634-42. PubMed ID: 9368620
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG, Oliveira MP, Da-Cruz AM, De Luca PM, Mendonça SC, Bertho AL, Soong L, McMahon-Pratt D.
    Exp Parasitol; 1996 Nov 01; 84(2):144-55. PubMed ID: 8932764
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL, Dutra WO, Martins FA, Gontijo B, Carvalho E, Barral-Netto M, Barral A, Almeida RP, Mayrink W, Locksley R, Gollob KJ.
    Infect Immun; 2001 May 01; 69(5):3232-9. PubMed ID: 11292745
    [Abstract] [Full Text] [Related]

  • 10. Up-regulation of Th1-type responses in mucosal leishmaniasis patients.
    Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, Gollob KJ, Carvalho EM.
    Infect Immun; 2002 Dec 01; 70(12):6734-40. PubMed ID: 12438348
    [Abstract] [Full Text] [Related]

  • 11. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G, Dorta ML, Santos NM, Mortara RA, Brodskyn C, Oliveira CI, Barbiéri CL, Rodrigues MM.
    Clin Vaccine Immunol; 2007 Sep 01; 14(9):1173-81. PubMed ID: 17626159
    [Abstract] [Full Text] [Related]

  • 12. The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.
    Kemp M, Handman E, Kemp K, Ismail A, Mustafa MD, Kordofani AY, Bendtzen K, Kharazmi A, Theander TG.
    FEMS Immunol Med Microbiol; 1998 Mar 01; 20(3):209-18. PubMed ID: 9566492
    [Abstract] [Full Text] [Related]

  • 13. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.
    O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML.
    Ann Surg; 1995 Oct 01; 222(4):482-90; discussion 490-2. PubMed ID: 7574928
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antigen-triggered interferon-γ and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease.
    Nogueira RS, Gomes-Silva A, Bittar RC, Silva Mendonça D, Amato VS, da Silva Mattos M, Oliveira-Neto MP, Coutinho SG, Da-Cruz AM.
    Clin Exp Immunol; 2014 Sep 01; 177(3):679-86. PubMed ID: 24773586
    [Abstract] [Full Text] [Related]

  • 19. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis.
    Oliveira WN, Ribeiro LE, Schrieffer A, Machado P, Carvalho EM, Bacellar O.
    Cytokine; 2014 Apr 01; 66(2):127-32. PubMed ID: 24485388
    [Abstract] [Full Text] [Related]

  • 20. Comparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice.
    Maspi N, Ghaffarifar F, Sharifi Z, Dalimi A, Dayer MS.
    Arch Immunol Ther Exp (Warsz); 2018 Feb 01; 66(1):55-64. PubMed ID: 28779346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.